NCT04759417

Brief Summary

Background: The STONE score has traditionally been used as a clinical prediction tool to predict the presence of ureteric stones in patients presenting with renal colic. More recently, the CHOKAI score was introduced and found to have superior diagnostic accuracy on both internal and external validation. Objective: Our study aims to externally validate and compare the use of both the CHOKAI and STONE score in a population of UAE patients presenting to the Emergency Department for renal colic. Methods: Over a period of approximately 6 months, the study will follow Emergency Department Physicians at each institution and retrieve data from their encounters with patients presenting with renal colic. Parameters for both CHOKAI and STONE scores will be logged, extracted and matched against a reference standard of CT scan to compare diagnostic accuracy of both scores to predict the presence of ureteric stones in this population. Goals: Evaluation of the findings will discern applicability of scores to the UAE population and contribute to reducing unnecessary radiation exposure. To our knowledge, no studies have compared the use of these scores to diagnose urolithiasis in the United Arab Emirates. Furthermore, this will be the first study to externally validate the CHOKAI score outside of Japan using a controlled, prospective design.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2021

Typical duration for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2021

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

February 3, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 18, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 25, 2024

Completed
Last Updated

July 29, 2024

Status Verified

July 1, 2024

Enrollment Period

1.2 years

First QC Date

February 3, 2021

Last Update Submit

July 25, 2024

Conditions

Keywords

ureteric stoneCHOKAISTONEUAErenal colic

Outcome Measures

Primary Outcomes (1)

  • Diagnostic accuracy comparison

    Compare the diagnostic accuracies of the CHOKAI and STONE scores in predicting the presence of ureteric stones by using differences in the area under the curve (AUC) between the CHOKAI and STONE scores, calculated using Receiver Operating Characteristic (ROC) analysis

    6 months

Secondary Outcomes (2)

  • Determine optimal cut-off point

    6 months

  • Rate of admission for patients

    6 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients presenting to the Emergency Department with symptoms suspicious of urolithiasis

You may qualify if:

  • Adult population (≥18 years of age) presenting to the Emergency Department with symptoms determined by the investigating ED Physician to be suspicious of urolithiasis (e.g. flank pain, lower abdominal pain, back pain and/or hematuria)
  • Patients suspected to have ureteric stone who underwent CT scan to confirm diagnosis

You may not qualify if:

  • Complicated ureteric colic:
  • Abnormal vital signs - body temperature \> 37.7 °C or systolic blood pressure ˂90 mmHg)
  • Active malignancy
  • Abnormal kidney function (abnormal levels of creatinine/BUN)
  • Recent (within past 6 months) trauma or urologic surgery
  • Age \<18 years
  • Pregnant patient
  • Patient with incomplete interview/documentation data (e.g. missing US/CT/ UA)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Sheikh Shakhbout Medical City

Abu Dhabi, United Arab Emirates

Location

Tawam Hospital

Abu Dhabi, United Arab Emirates

Location

Zayed Military Hospital

Abu Dhabi, United Arab Emirates

Location

MeSH Terms

Conditions

UreterolithiasisRenal Colic

Condition Hierarchy (Ancestors)

Ureteral DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisMale Urogenital DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mohammad Anzal Rehman, MD

    Zayed Military Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Emergency Medicine Resident

Study Record Dates

First Submitted

February 3, 2021

First Posted

February 18, 2021

Study Start

February 1, 2021

Primary Completion

March 31, 2022

Study Completion

July 25, 2024

Last Updated

July 29, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

The protocol for selection of patients used for prospective data collection shall be made available for the entirety of the study duration, including the Informed Consent Form we will use during patient encounters. The Statistical Analysis Plan (SAP) will be shared after results are compiled (approximately in 6 months from study start date) and processed by the biostatistician for a period of 3 months

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Protocol and Informed Consent data will be available for 6 months from study start date Study Analysis Plan (SAP) will be available for 3 months once data collection is completed and results compiled for analysis
Access Criteria
Any interested researcher can approach the Principal Investigator, Mohammad Anzal Rehman, at chokai.study@outlook.com for any of the details listed above within the time frames mentioned for access to the same.

Locations